NovaDigm Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:NovaDigm Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013964
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, ALS3 vaccines, vaccine clinical supplies, bacterial and fungal vaccine antigens, vaginal and bloodstream infections treatment vaccines, and fungal and bacterial pathogens vaccines. Its other products comprise vulvovaginal candidiasis vaccines, RWC treatment vaccines, skin and soft tissue infection treatment vaccines, nosocomial infection vaccines, venous catheters, endothelial cells, and feeding tubes, among others. NovaDigm offers services such as clinical trials, clinical discoveries, candidates development, preclinical studies, and invasive medical devices development services. The company’s products are used in treatment of skin, mucosal, and life-threatening systemic infections. NovaDigm is headquartered in Brookline, Massachusetts, the US.

NovaDigm Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 10
NovaDigm Therapeutics Acquires Rights to Secreted Aspartyl Proteinase 2 from Pevion Biotech and Italian National Health Institute 11
Venture Financing 12
NovaDigm Therapeutics Raises US$14 Million In Series B Financing 12
NovaDigm Therapeutics Raises US$10 Million In Extended Series A Financing 14
NovaDigm Therapeutics Raises Additional US$4 Million In Series A Financing 15
Licensing Agreements 16
NovaDigm Therapeutics Enters into Licensing Agreement with Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 16
NovaDigm Therapeutics Inc – Key Competitors 17
NovaDigm Therapeutics Inc – Key Employees 18
NovaDigm Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Clinical Trials 20
Aug 15, 2016: NovaDigm Therapeutics Announces Positive Results from First-ever Antifungal Immunotherapy in a Phase 2a Study in Women with Recurrent Vulvovaginal Candidiasis 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NovaDigm Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 10
NovaDigm Therapeutics Acquires Rights to Secreted Aspartyl Proteinase 2 from Pevion Biotech and Italian National Health Institute 11
NovaDigm Therapeutics Raises US$14 Million In Series B Financing 12
NovaDigm Therapeutics Raises US$10 Million In Extended Series A Financing 14
NovaDigm Therapeutics Raises Additional US$4 Million In Series A Financing 15
NovaDigm Therapeutics Enters into Licensing Agreement with Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 16
NovaDigm Therapeutics Inc, Key Competitors 17
NovaDigm Therapeutics Inc, Key Employees 18

★海外企業調査レポート[NovaDigm Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • B. Braun Melsungen AG:企業の戦略・SWOT・財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TransAlta Corporation (TA)-エネルギー分野:企業M&A・提携分析
    Summary TransAlta Corporation (TransAlta) is an electricity generation company. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geothermal. TransAlta's service portfolio comprises commercial and industrial energy service …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Medherant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary CCM Duopharma Biotech Bhd (CCMD), a subsidiary of Chemical Company of Malaysia Bhd, is a pharmaceutical company that develops, manufactures and markets generic drugs and branded pharmaceutical products. The company offers products in the form of tablets, capsules, syrup, oral antibiotic, cre …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …
  • Flex Ltd.:企業の戦略・SWOT・財務分析
    Flex Ltd. - Strategy, SWOT and Corporate Finance Report Summary Flex Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Cellmid Ltd (CDY):医療機器:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Sandoz International GmbH:企業の戦略・SWOT・財務分析
    Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BaxterStorey Ltd:企業の戦略・SWOT・財務分析
    BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report Summary BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Scienion AG-医療機器分野:企業M&A・提携分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Comvita Ltd (CVT):企業の財務・戦略的SWOT分析
    Comvita Ltd (CVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Anadarko Petroleum Corp (APC):企業の財務・戦略的SWOT分析
    Anadarko Petroleum Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆